Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center Pilot Study to Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) Treatments In Patients With Acute Renal Failure (ARF)

NCT01072682 is registered in ClinicalTrials.gov with SeaStar Medical as lead sponsor.

NCT NCT01072682
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01072682 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center Pilot Study to Assess the Safety and Efficacy of A Selective Cytopheretic Device (SCD) Treatments In Patients With Acute Renal Failure (ARF)
Lead sponsor
SeaStar Medical
Phase
Not applicable
Overall status
Completed
Start date
February 28, 2010
Completion date
May 31, 2011
Enrollment
35 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

acute renal failure